Carboplatin 10 MG/ML Injectable Solution [Kyxata] — RxCUI 2721602
RxNorm drug concept · Semantic branded drug
RxCUI 2721602
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2721602
Official nameCarboplatin 10 MG/ML Injectable Solution [Kyxata]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asKyxata 20 MG per 2 ML Injectable Solution; KYXATA 10 MG/ML Injectable Solution; Kyxata 500 MG per 50 ML Injectable Solution; Kyxata 80 MG per 8 ML Injectable Solution
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Carboplatin Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Carboplatin is a chemotherapy drug used to treat advanced ovarian cancer. Depending on where you are in your treatment, it may be given in combination with another drug called cycl...
- What exactly is carboplatin being used to treat in my case?
- Carboplatin is given as an IV infusion directly into your vein — you can't take it as a pill. You'll receive it at a hospital or infusion clinic, and the session typically happens...
- How will I actually get this medication — do I swallow it or does it go into my arm?
🕸️ Concept Web — How Carboplatin 10 MG/ML Injectable Solution [Kyxata... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carboplatin 10 MG/ML Injectable Solution [Kyxata]
RxCUI 2721602 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Carboplatin
40048IN
-
Carboplatin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Kyxata
2721598BN
-
Kyxata
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carboplatin Injectable Solution
378363SCDF -
Carboplatin Injectable Product
1156104SCDG -
Carboplatin Injectable Solution [Kyxata]
2721601SBDF -
Kyxata Injectable Product
2721600SBDG -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
Carboplatin Injectable Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carboplatin 10 MG/ML Injectable Solution
597195SCD -
Carboplatin 10 MG/ML
346209SCDC -
Carboplatin 10 MG/ML [Kyxata]
2721599SBDC
-
Carboplatin 10 MG/ML Injectable Solution
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carboplatin 10 MG/ML Injectable Solution
SCD · 597195 -
Carboplatin 10 MG/ML
SCDC · 346209 -
Carboplatin Injectable Solution
SCDF · 378363 -
Carboplatin Injectable Product
SCDG · 1156104
Brand-Name Concepts
-
Carboplatin 10 MG/ML [Kyxata]
SBDC · 2721599 -
Carboplatin Injectable Solution [Kyxata]
SBDF · 2721601 -
Kyxata Injectable Product
SBDG · 2721600 -
Kyxata
BN · 2721598
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 2721602 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 83831-0141-08 | 1 VIAL, MULTI-DOSE in 1 CARTON (83831-141-08) / 8 mL in 1 V... | KYXATA | Avyxa Pharma, LLC | 2025-09-10 |
| 83831-0142-50 | 1 VIAL, MULTI-DOSE in 1 CARTON (83831-142-50) / 50 mL in 1... | KYXATA | Avyxa Pharma, LLC | 2025-09-10 |
Observed labelers:
Avyxa Pharma, LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9278 | Inj, carboplatin (avyxa) | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.